Author

Pete J. Gough

GlaxoSmithKline (United States)

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Approach:experimental assay· 1 Organism:mouse· 1

Frequent Co-Authors

Aivi T. NguyeniD· 1 shared Ari M. MelnickiD· 1 shared Chaim T. SneidermaniD· 1 shared Dong HuiD· 1 shared Gabriela Nogueira DebomiD· 1 shared Gary KohanbashiD· 1 shared Hannah E. CrentsiliD· 1 shared J. Hofstatter AzambujaiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Aivi T. NguyenORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

MALT1 protease inhibition restrains glioblastoma progression by reversing tumor-associated macrophage-dependent immunosuppression

J. Hofstatter Azambuja, Saigopalakrishna S. Yerneni, Lisa M. Maurer, Hannah E. Crentsil, Gabriela Nogueira Debom, Linda R. Klei, Mei Smyers, Chaim T. Sneiderman, Kristina Elsa Schwab, Rajesh Acharya, Aivi T. Nguyen, Josie L. Emery, John W. Little, Jeffrey A. Meridew, Yijen Lin Wu, , Linda M. McAllister‐Lucas

This study shows that inhibiting MALT1 protease in glioblastoma-associated macrophages reduces immunosuppression and tumor growth by reprogramming macrophages to an M1-like phenotype.

Nature Communications · Aug 10, 2026Peer-reviewedCancer Biology